Targeting T Cells with Bispecific Antibodies for Cancer Therapy

Author： Lum Lawrence G.   Thakur Archana  

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.25, Iss.6, 2011-12, pp. : 365-379

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bispecific Antibodies for Cancer Immunotherapy: Current Perspectives

By Müller Dafne   Kontermann Roland E.  

BioDrugs, Vol. 24, Iss. 2, 2010-04 ,pp. : 89-98

Adis International

Access to resources Recommend Favorite

Monoclonal Antibodies Targeting Vascular Endothelial Growth Factor: Current Status and Future Challenges in Cancer Therapy

By Hsu Jerry Y.   Wakelee Heather A.  

BioDrugs, Vol. 23, Iss. 5, 2009-10 ,pp. : 289-304

Adis International

Access to resources Recommend Favorite

Transposon-Based Engineering of Clinical-Grade T Cells for Cancer Therapy

By  

Current Drug Therapy, Vol. 7, Iss. 1, 2012-03 ,pp. : 36-41

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Mitosis for Anti-Cancer Therapy

By Sudakin Valery  

BioDrugs, Vol. 21, Iss. 4, 2007-01 ,pp. : 225-233

Adis International

Access to resources Recommend Favorite

Microtubule Targeting Agents: A Benchmark in Cancer Therapy

By  

Current Drug Therapy, Vol. 8, Iss. 3, 2013-09 ,pp. : 189-196

Bentham Science Publishers

Access to resources Recommend Favorite